Ethiopia Secures Global Laboratory Accreditation to Boost Animal Products, and Inputs Quality and Safety
This international certification, awarded on 25 April 2025 during a high-level event at Haile Grand Hotel in Addis Ababa, Ethiopia, recognized the Center's capacity to perform laboratory tests to globally accepted standards.
This milestone strengthens Ethiopia's ability to ensure the safety and quality of animal products and inputs, prevent and contain the spread of antimicrobial resistance (AMR), and safeguard human, animal, and environmental health through a One Health approach.
Accreditation to ISO/IEC 17025:2017 confirms the APIQTC's technical competence in performing on thirteen parameters on veterinary pharmaceutical quality; Aflatoxin residue monitoring in animal source food and feed, and microbiological analysis.
These functions are vital for independently verifying animal products and inputs quality and adherence to international trade requirements and supporting public confidence. In a country where livestock plays a central role in the economy, such capabilities are indispensable for market access, trade, and sustainable agricultural development.
FAO's Strategic Role
The Food and Agriculture Organization of the United Nations (FAO) in Ethiopia was recognized during the ceremony for its long-standing health system strengthening support of the regulatory frameworks and laboratory capacity of APIQTC. FAO's technical and logistical assistance was instrumental in achieving this global standard.
Minister of Agriculture, H.E. Dr. Girma Amente, praised the achievement during the event, stating that, 'ISO accreditation is critical for Ethiopia's agricultural sustainability and public health security. This international recognition reflects our commitment to quality assurance and our readiness to meet global food safety standards.'
Looking Ahead
More than a technical certification, this accreditation marks a turning point for Ethiopia's livestock and agriculture sectors. It signals the country's growing capacity to independently ensure animal products and inputs safety and quality, mitigate Antimicrobial Resistance (AMR) threats, and meet the demands of markets.
Aligned with FAO's global vision for better production, better nutrition, a better environment, and a better life, this achievement positions Ethiopia to move forward with confidence toward sustainable agrifood systems transformation.
Distributed by APO Group on behalf of Food and Agriculture Organization of the United Nations (FAO): Regional Office for Africa.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
10 hours ago
- Khaleej Times
Dubai residents call out 'disrespectful' vaping in malls amid rising inspections
Dubai Municipality has stepped up inspections in shopping centres across the emirate after receiving complaints about people vaping indoors, in violation of UAE laws banning smoking and e-cigarettes in enclosed public spaces. In response to the complaint, which raised concerns about the rising number of people using vapes in malls, the authority confirmed that several measures are already in place to curb the behaviour. 'Dubai Municipality, represented by the Health and Safety Department, has taken a set of measures in coordination with shopping centre operators to address the smoking phenomenon,' the authority said in a statement on X. These include installing clear signage at entrances and corridors, requiring security guards to monitor and alert violators, and issuing instructions to shops and restaurants to enforce the ban. Smoking near entrances and exits is also prohibited, with designated areas located at least seven metres away from such spots. The authority also confirmed it conducts regular inspection rounds to ensure compliance, with the goal of 'protecting public health and promoting a smoke-free environment". Despite the municipality's actions and multiple warnings, some residents say vaping indoors is still a common sight. 'It feels disrespectful,' said Sana Rahim, a Sharjah-based mother of two who frequently visits Dubai malls with her children. 'You're walking with your kids and suddenly someone walks past blowing vape smoke. It's not just unpleasant, it's sending the wrong message to children — that this is normal and acceptable behaviour indoors.' Sana added that the issue feels out of place in a country known for its order and respect for public spaces. 'UAE residents and citizens are known for being law-abiding and sophisticated. This is a new sight and something we hadn't seen before,' she said. 'Even if it's an electronic cigarette and not a real cigarette and doesn't produce any waste, that's not the reason for banning it inside. This isn't its place.' Vaping laws in the UAE While the sale of vaping devices and e-liquids has been legal in the UAE since mid-April 2019 under strict regulations set by the Emirates Authority for Standardisation and Metrology (Esma), the law clearly prohibits their use indoors. That includes malls, offices, airports (except in designated areas), and hospitals. Dubai Municipality has also banned smoking shisha in parks, beaches, and public recreational spaces. It requires special licences for shisha cafes, which must not operate within 150 metres of schools, mosques, or residential areas. Pregnant women are not allowed to enter shisha cafes, even if they don't intend to smoke. Another resident, Saeed Al Mazrouei, said he recently witnessed a teenager vaping openly at a food court. 'No one said anything to him. There were families around, young kids, and it's like no one cared,' he said. 'Just because it smells like bubble gum doesn't make it any less harmful.' Not a grey area, doctors say While some people may view vaping as a 'healthier' alternative to smoking, doctors continue to warn against the risks of both direct and second-hand exposure. Speaking to Khaleej Times, Dr Biniyam Tefera, a consultant pulmonologist based in Dubai, said second-hand vape aerosol can carry health risks, especially in non-ventilated areas like malls. 'People often assume that because vape smoke looks less dense or smells pleasant, it's safe, but that's not the case,' said Dr Tefera. 'Second-hand vape exposure can contain nicotine, heavy metals, and other harmful chemicals. Over time, this can affect lung function, especially in children, elderly people, and those with respiratory conditions.' He noted that even brief exposure in confined public areas could pose risks to people with asthma or underlying lung issues. 'The chemicals inhaled aren't just water vapour, and that misconception is dangerous,' he said. 'The long-term impact of chronic passive exposure is still being studied, but what we already know is enough to justify stricter enforcement.' He added that enforcing vape-free zones in malls is 'not just a policy issue, but a health protection matter".
Zawya
14 hours ago
- Zawya
Ethiopia's Integrated Measles Campaign Reaches 18.5 Million Under-Five Children
Ethiopia has successfully concluded its 2025 nationwide integrated measles campaign, reaching 18,570,244 children—99% of the targeted population. The ten-day campaign began on 14 May 2025 across 12 regions, with Somali Region and Addis Ababa City Administration launching on 21 May and 26 May, respectively. The national launch event, organized by WHO, was held in Bishoftu, Oromia Region, under the leadership of the Ministry of Health and supported by partners, community members, and political leaders. Dr. Owen L. Kaluwa, WHO Representative to Ethiopia, commended the Ministry of Health for its leadership, stating: 'I would like to congratulate and commend the Ministry of Health for your leadership and effort undertaken to realize the successful implementation of the 2025 National Integrated Measles Supplementary Immunization (SIA) Campaign, and for marking a significant milestone in delivering life-saving services to vulnerable and hard-to-reach populations nationwide.' Dr. Kaluwa also reaffirmed WHO's commitment to supporting Ethiopia in strengthening routine immunization and primary health care systems to reduce child mortality. WHO provided technical and financial support throughout the campaign, including proposal development, microplanning, training, supervision, and support for the national launch event. The campaign targeted children aged 9 to 59 months, aiming to protect them against measles—a highly contagious and potentially fatal disease. It was designed to close immunity gaps and prevent outbreaks, in line with global health recommendations and in response to ongoing measles cases in parts of the country. In addition to measles vaccination, the campaign integrated several health interventions, including: Routine Immunization: 191,346 zero-dose and 211,546 under-vaccinated children received vaccines. Nutritional Screening: Over 18.9 million children under five were screened; 874,722 were identified as moderately acutely malnourished (MAM), and 122,207 as severely acutely malnourished (SAM). Vitamin A Supplementation: More than 15 million children received vitamin A. Deworming: 11,095,948 children aged 24 to 59 months received albendazole. COVID-19 Vaccination: 206,431 Pfizer doses were administered to high-priority groups. Obstetric Fistula Identification: 1,325 suspected cases were identified and referred to health facilities. Sick Child Referral: Over 49,312 sick children were identified and linked to appropriate health services. The campaign's success was made possible through the full engagement of government ministries, partners, communities, and the media, which played a vital role in raising awareness and increasing demand for the life-saving vaccine. This achievement highlights the power of collaboration and dedicated partnerships in ensuring every child has access to essential health services. WHO remains steadfast in its commitment to supporting Ethiopia in strengthening routine immunization, enhancing primary health care systems, and advancing efforts to reduce child mortality—ensuring that no child is left behind. Distributed by APO Group on behalf of World Health Organization (WHO) - Ethiopia.
Zawya
14 hours ago
- Zawya
Ethiopia Completes Second Round of novel Oral Polio Vaccine type 2 (nOPV2) Campaign, Reaching Over 16.8 Million Children with Integrated Health Services
Ethiopia has successfully concluded the second round of its nationwide novel oral polio vaccine type 2 (nOPV2) campaign, reaching more than 16.8 million children across ten regions. Led by the Ministry of Health and the Ethiopian Public Health Institute and supported by the World Health Organization (WHO), UNICEF, Rotary International, and other immunization partners, the campaign was conducted from 30 May to 2 June 2025. With an administrative coverage of 105%, the campaign integrated essential maternal and child health services to maximize its reach and impact. While the primary target group was children under five, the age range was extended to include children up to ten years in Kellem and West Guji zones of Oromia Region, following localized risk assessments. 'Ethiopia's leadership and coordination have been exemplary,' said Dr Owen L. Kaluwa, WHO Representative in Ethiopia. 'In the first round, over 15.3 million children were vaccinated with nOPV2, achieving 103% coverage. These efforts are vital as the country continues to respond to outbreaks, with 69 cases reported across multiple regions between 2024 and March 2025.' Throughout the campaign, WHO played a pivotal role in ensuring its success. In close collaboration with the Ethiopian Public Health Institute and UNICEF, WHO supported pre-campaign preparations, including resource mobilization, training of health workers, and real-time monitoring using tools like the Open Data Kit (ODK). WHO also deployed independent monitors and quality assurance surveyors in nearly half of the selected regions, enabling immediate corrective actions and contributing to higher coverage rates. Additionally, WHO Field Officers and STOP consultants supported preparedness assessments, microplanning, cold chain inventory, and training of team supervisors. The integrated campaign strategy is central to reducing mortality and morbidity from vaccine-preventable diseases. During the first round, a total of 104,000 zero-dose (62,000) and under-vaccinated children (42,000) were identified and vaccinated—highlighting the campaign's success in reaching previously missed populations. Key Achievements from the Second Round are: 48,363 zero-dose children vaccinated, bringing the cumulative total to over 110,000 across both rounds. 654 children immunized at official border entry points with Sudan, Kenya, Somalia, and South Sudan. 31,253 supervisory visits conducted, resulting in 365 acute flaccid paralysis (AFP) alerts, with 81 confirmed cases and samples collected for laboratory analysis. Independent monitoring and Lot Quality Assurance Sampling (LQAS) surveys confirmed high campaign quality, with 98% of 52,120 children verified as vaccinated and 90% of lots passing the quality threshold. In addition to nOPV2 vaccination, the campaign facilitated catch-up immunizations for zero-dose and under-vaccinated children and supported the identification and referral of women with obstetric fistula for treatment—demonstrating a holistic approach to public health. WHO remains committed to supporting Ethiopia's regions, zones, and woredas in achieving high immunization coverage and maintaining robust disease surveillance systems to protect every child. Distributed by APO Group on behalf of World Health Organization (WHO) - Ethiopia.
